Great Lakes Advisors LLC Makes New $4.49 Million Investment in Privia Health Group, Inc. $PRVA

Great Lakes Advisors LLC acquired a new position in Privia Health Group, Inc. (NASDAQ:PRVA) during the 3rd quarter, Holdings Channel reports. The fund acquired 180,183 shares of the company’s stock, valued at approximately $4,487,000.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the stock. Qube Research & Technologies Ltd raised its stake in Privia Health Group by 93.3% in the 2nd quarter. Qube Research & Technologies Ltd now owns 609,278 shares of the company’s stock valued at $14,013,000 after purchasing an additional 294,101 shares during the last quarter. Cubist Systematic Strategies LLC acquired a new position in shares of Privia Health Group in the 2nd quarter valued at about $6,219,000. First Trust Advisors LP lifted its position in Privia Health Group by 482.7% during the second quarter. First Trust Advisors LP now owns 279,005 shares of the company’s stock valued at $6,417,000 after buying an additional 231,125 shares in the last quarter. Advantage Alpha Capital Partners LP acquired a new position in shares of Privia Health Group during the 2nd quarter valued at $3,941,000. Finally, Geode Capital Management LLC lifted its stake in shares of Privia Health Group by 6.3% during the second quarter. Geode Capital Management LLC now owns 2,655,569 shares of the company’s stock worth $61,086,000 after purchasing an additional 158,521 shares in the last quarter. Hedge funds and other institutional investors own 94.48% of the company’s stock.

Analysts Set New Price Targets

Several equities research analysts recently issued reports on PRVA shares. Royal Bank Of Canada initiated coverage on shares of Privia Health Group in a research note on Friday, January 9th. They set an “outperform” rating and a $31.00 price target on the stock. BMO Capital Markets assumed coverage on Privia Health Group in a research report on Thursday, November 13th. They issued an “outperform” rating and a $30.00 target price for the company. Truist Financial reaffirmed a “buy” rating and issued a $31.00 price target (up from $30.00) on shares of Privia Health Group in a report on Monday, November 10th. Canaccord Genuity Group boosted their price objective on Privia Health Group from $32.00 to $34.00 and gave the company a “buy” rating in a research report on Wednesday, November 12th. Finally, Wolfe Research set a $31.00 target price on shares of Privia Health Group in a research note on Tuesday, January 6th. Thirteen research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $30.50.

Insider Activity

In other Privia Health Group news, CFO David Mountcastle sold 23,887 shares of the stock in a transaction that occurred on Friday, December 12th. The stock was sold at an average price of $25.03, for a total transaction of $597,891.61. Following the transaction, the chief financial officer owned 172,909 shares in the company, valued at $4,327,912.27. This trade represents a 12.14% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Director Matthew Shawn Morris sold 13,647 shares of the firm’s stock in a transaction dated Friday, December 12th. The shares were sold at an average price of $25.01, for a total value of $341,311.47. Following the completion of the sale, the director directly owned 68,188 shares in the company, valued at approximately $1,705,381.88. This represents a 16.68% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. 10.70% of the stock is owned by insiders.

Privia Health Group Trading Up 1.5%

Shares of PRVA opened at $23.22 on Friday. Privia Health Group, Inc. has a 1-year low of $18.77 and a 1-year high of $26.51. The business’s 50-day moving average price is $23.83 and its 200 day moving average price is $23.13. The stock has a market capitalization of $2.86 billion, a P/E ratio of 178.63, a P/E/G ratio of 1.61 and a beta of 0.83.

Privia Health Group (NASDAQ:PRVA) last issued its earnings results on Thursday, November 6th. The company reported $0.29 EPS for the quarter, topping the consensus estimate of $0.06 by $0.23. Privia Health Group had a return on equity of 2.52% and a net margin of 0.89%.The business had revenue of $580.42 million during the quarter, compared to analysts’ expectations of $494.98 million. During the same quarter last year, the firm posted $0.20 earnings per share. Privia Health Group’s revenue was up 32.5% compared to the same quarter last year. On average, research analysts predict that Privia Health Group, Inc. will post 0.14 earnings per share for the current year.

Privia Health Group Profile

Privia Health Group (NASDAQ: PRVA) is a physician enablement company that partners with independent physicians, medical groups and health systems to transform the delivery of patient care. Through a clinically integrated network and a proprietary technology platform, the company supports providers in managing population health, delivering coordinated care and optimizing financial performance under both fee-for-service and value-based reimbursement models.

Founded in 2016 and headquartered in McLean, Virginia, Privia Health has rapidly expanded its footprint to serve multiple metropolitan markets across the United States.